These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16988893)

  • 41. Prediction of recidivism in extrafamilial child molesters based on court-related assessments.
    Firestone P; Bradford JM; McCoy M; Greenberg DM; Curry S; Larose MR
    Sex Abuse; 2000 Jul; 12(3):203-21. PubMed ID: 10904992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depo-Provera: just another contraceptive?
    Jones M
    Fertil Contracept; 1978 Apr; 2(2):26-9. PubMed ID: 12336094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ask the experts: progestin-only contraceptives.
    Hatcher RA; Schnare S
    Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of prison-based treatment on sex offender recidivism: evidence from Minnesota.
    Duwe G; Goldman RA
    Sex Abuse; 2009 Sep; 21(3):279-307. PubMed ID: 19531811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of Depo-Provera in East London.
    Savage W
    Fertil Contracept; 1978 Jul; 2(3):41-7. PubMed ID: 12260723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depo-provera: contraceptive risk?
    Rosenfield A
    Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sexual predator civil commitment: a comparison of selected and released offenders.
    Levenson JS
    Int J Offender Ther Comp Criminol; 2004 Dec; 48(6):638-48. PubMed ID: 15538023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for adolescent sex offender recidivism: evaluation of predictive factors and comparison of three groups based upon victim type.
    Parks GA; Bard DE
    Sex Abuse; 2006 Oct; 18(4):319-42. PubMed ID: 17136626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Teens and Depo-Provera: a good match?
    Contracept Technol Update; 1995 Jul; 16(7):86-8. PubMed ID: 12346507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study.
    Venkatachalam S; Bagratee JS; Moodley J
    J Obstet Gynaecol; 2004 Oct; 24(7):798-800. PubMed ID: 15763792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examining the criminal history and future offending of child pornography offenders: an extended prospective follow-up study.
    Eke AW; Seto MC; Williams J
    Law Hum Behav; 2011 Dec; 35(6):466-78. PubMed ID: 21088873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk assessment of sexual offenders for extended supervision orders in New Zealand: basic principles and current practice.
    Vess J
    J Child Sex Abus; 2009; 18(2):174-89. PubMed ID: 19306205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparing recidivism rates of treatment responders/nonresponders in a sample of 413 child molesters who had completed community-based sex offender treatment in the United kingdom.
    Beech AR; Mandeville-Norden R; Goodwill A
    Int J Offender Ther Comp Criminol; 2012 Feb; 56(1):29-49. PubMed ID: 21187301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sentencing outcomes of convicted child sex offenders.
    Patrick S; Marsh R
    J Child Sex Abus; 2011 Jan; 20(1):94-108. PubMed ID: 21259149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What is breast cancer risk with Depo-Provera?
    Contracept Technol Update; 1992 Jan; 13(1):15-6. PubMed ID: 12343459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholelithiasis associated with medroxyprogesterone acetate therapy in men.
    Meyer WJ; Wiener I; Emory LE; Cole CM; Isenberg N; Fagan CJ; Thompson JC
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):69-84. PubMed ID: 1385654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 25-year follow-up of cognitive/behavioral therapy with 7,275 sexual offenders.
    Maletzky BM; Steinhauser C
    Behav Modif; 2002 Apr; 26(2):123-47. PubMed ID: 11961909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.